Leuprorelin
Sold as Lucrin depot, Eligard, Leuprolide hexal
No structure available
This product's active ingredient could not be matched to a single known compound.
Background
Registration
- Applicants
- 3
- Registrations
- 7
- Schedule source
- SAHPRA documentation
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Abbvie (Pty) Ltd | Lucrin depot | 3,75, 11,25 | 270370, 320317 | Not determined | None |
| Key Oncologics (Pty) Ltd1 of 4 cancelled | Eligard | 7,5 mg, 22,5 mg, 30 mg, 45 mg | A390648, A390649, A390650, A390651 | Not determined | None |
| Sandoz South Africa (Pty) Ltd | Leuprolide hexal | 5.2MG | A400263 | S4 | PIPIL |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Lucrin depot 3,75* EACH VIAL CONTAINS LEUPRORELIN ACETATE 3,75 mg | 3,75 | 27037027/21.10/0370 | Registered | Not determined | None |
| Lucrin depot 11,25 EACH VIAL CONTAINS LEUPRORELIN ACETATE 11,25 mg | 11,25 | 32031732/21.10/0317 | Registered | Not determined | None |
| Eligard 7,5 MG EACH SYRINGE CONTAINS LEUPRORELIN ACETATE 7,5 mg | 7,5 mg | A390648A39/26/0648 | Registered | Not determined | None |
| Eligard 22,5 MG EACH SYRINGE CONTAINS LEUPRORELIN ACETATE 22,5 mg | 22,5 mg | A390649A39/26/0649 | Registered | Not determined | None |
| Eligard 30 MG EACH SYRINGE CONTAINS LEUPRORELIN ACETATE 30,0 mg | 30 mg | A390650A39/26/0650 | Cancelled | Not determined | None |
| Eligard 45 MG EACH SYRINGE CONTAINS LEUPRORELIN ACETATE 45,0 mg | 45 mg | A390651A39/26/0651 | Registered | Not determined | None |
| Leuprolide hexal 5 EACH IMPLANT CONTAINS LEUPRORELIN ACETATE EQUIVALENT TO LEUPRORELIN 5,0 mg | 5.2MGImplant | A400263A40/21.10/0263Approved 10 August 2018 | Registered | S4 | PIPIL |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Leuprolide hexal 5, Sandoz South Africa (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.